Published in J Biol Chem on July 10, 1979
Comparison of initiation of protein synthesis in procaryotes, eucaryotes, and organelles. Microbiol Rev (1983) 24.58
Sequence specificity of the human mRNA N6-adenosine methylase in vitro. Nucleic Acids Res (1990) 1.73
Accumulation of spliced avian retrovirus mRNA is inhibited in S-adenosylmethionine-depleted chicken embryo fibroblasts. J Virol (1982) 1.72
Direct analysis of the mini-exon donor RNA of Trypanosoma brucei: detection of a novel cap structure also present in messenger RNA. Nucleic Acids Res (1987) 1.72
Effect of undermethylation on mRNA cytoplasmic appearance and half-life. Mol Cell Biol (1984) 1.46
N6-methyl-adenosine (m6A) in RNA: an old modification with a novel epigenetic function. Genomics Proteomics Bioinformatics (2012) 1.41
Selective inhibition of avian sarcoma virus protein synthesis in 3-deazaadenosine-treated infected chicken embryo fibroblasts. J Virol (1981) 0.80
Multiplicity of 5' cap structures present on short RNAs. PLoS One (2014) 0.77
Virus-specific proteins synthesized in encephalomyocarditis virus-infected HeLa cells. Proc Natl Acad Sci U S A (1971) 4.20
Structure of B77 sarcoma virus RNA: stabilization of RNA after packaging. J Virol (1975) 2.59
Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors. Mol Cell Biol (1995) 2.51
Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1. Mol Cell Biol (1994) 2.35
The Urabe AM9 mumps vaccine is a mixture of viruses differing at amino acid 335 of the hemagglutinin-neuraminidase gene with one form associated with disease. J Infect Dis (1996) 2.35
Herpes simplex virus thymidine kinase transcripts are absent from both nucleus and cytoplasm during infection in the presence of cycloheximide. J Virol (1980) 1.86
Sequence specificity of internal methylation in B77 avian sarcoma virus RNA subunits. Biochemistry (1977) 1.80
A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H. J Biol Chem (2001) 1.77
Accumulation of spliced avian retrovirus mRNA is inhibited in S-adenosylmethionine-depleted chicken embryo fibroblasts. J Virol (1982) 1.72
Noncoding region between the env and src genes of Rous sarcoma virus influences splicing efficiency at the src gene 3' splice site. J Virol (1987) 1.68
Splicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3' splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2. Nucleic Acids Res (1997) 1.61
Capsid polypeptides of mouse Elberfeld virus. I. Amino acid compositions and molar ratios in the virion. J Virol (1972) 1.61
Gene expression from both intronless and intron-containing Rous sarcoma virus clones is specifically inhibited by anti-sense RNA. Mol Cell Biol (1985) 1.58
Avian sarcoma virus gag and env gene structural protein precursors contain a common amino-terminal sequence. Proc Natl Acad Sci U S A (1984) 1.55
The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55). J Virol (1996) 1.49
Structural characterization of virion proteins and genomic RNA of human parainfluenza virus 3. J Virol (1984) 1.46
Frameshift mutations in the v-src gene of avian sarcoma virus act in cis to specifically reduce v-src mRNA levels. Mol Cell Biol (1994) 1.45
The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly. Mol Cell Biol (1998) 1.44
A suboptimal src 3' splice site is necessary for efficient replication of Rous sarcoma virus. Virology (1995) 1.43
The fusion and hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus 3 are both required for fusion. Virology (1991) 1.43
Cloning and nucleotide sequences of cDNAs spanning the splice junctions of Rous sarcoma virus mRNAs. J Virol (1985) 1.42
RNA splicing at human immunodeficiency virus type 1 3' splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element. J Virol (2001) 1.41
The structure of mouse-Elberfeld virus: a model. Proc Natl Acad Sci U S A (1969) 1.40
Conserved stem-loop structures in the HIV-1 RNA region containing the A3 3' splice site and its cis-regulatory element: possible involvement in RNA splicing. Nucleic Acids Res (2001) 1.37
Numerous transitions in human parainfluenza virus 3 RNA recovered from persistently infected cells. Virology (1991) 1.33
A base-paired structure in the avian sarcoma virus 5' leader is required for efficient encapsidation of RNA. J Virol (1994) 1.29
Inhibition of Rous sarcoma virus replication by antisense RNA. J Virol (1987) 1.26
Gene mapping in Pichinde virus: assignment of viral polypeptides to genomic L and S RNAs. J Virol (1983) 1.19
Analyses of the genomes of prototype pichinde arenavirus and a virulent derivative of Pichinde Munchique: evidence for sequence conservation at the 3' termini of their viral RNA species. Virology (1982) 1.18
Two distant upstream regions containing cis-acting signals regulating splicing facilitate 3'-end processing of avian sarcoma virus RNA. J Virol (1992) 1.17
Stabilities of avian sarcoma virus RNAs: comparison of subgenomic and genomic species with cellular mRNAs. J Gen Virol (1983) 1.16
Absence of polyadenylic acid from reovirus messenger ribonucleic acid. J Biol Chem (1973) 1.14
Mutations in the regions of the Rous sarcoma virus 3' splice sites: implications for regulation of alternative splicing. J Virol (1991) 1.14
Comparison of Rous sarcoma virus RNA processing in chicken and mouse fibroblasts: evidence for double-spliced RNA in nonpermissive mouse cells. J Virol (1990) 1.13
Rous sarcoma virus direct repeat cis elements exert effects at several points in the virus life cycle. J Virol (1997) 1.12
Negative and positive mRNA splicing elements act competitively to regulate human immunodeficiency virus type 1 vif gene expression. J Virol (2008) 1.11
Poly(A) polymerase activity in reovirus. J Virol (1974) 1.09
Size estimation of Pichinde virus RNA by gel electrophoresis under denaturing conditions. Intervirology (1980) 1.09
Two oligonucleotide classes of single-stranded ribopolymers in reovirus A-rich RNA. Arch Biochem Biophys (1972) 1.07
Evidence for the identity of shared 5'-terminal sequences between genome RNA and subgenomic mRNA's of B77 avian sarcoma virus. J Virol (1979) 1.05
Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains. J Virol (1999) 1.05
Nucleotide sequence of the coding and flanking regions of the human parainfluenza virus 3 hemagglutinin-neuraminidase gene: comparison with other paramyxoviruses. Intervirology (1987) 1.03
Mutations of the human cytomegalovirus immediate-early 2 protein defines regions and amino acid motifs important in transactivation of transcription from the HIV-1 LTR promoter. Virology (1993) 1.00
Cycloleucine blocks 5'-terminal and internal methylations of avian sarcoma virus genome RNA. Biochemistry (1978) 0.98
Nucleotide sequence of the coding and flanking regions of the human parainfluenza virus type 3 fusion glycoprotein gene. J Gen Virol (1987) 0.96
3'-Terminal sequence of human parainfluenza virus 3 genomic RNA. Nucleic Acids Res (1986) 0.96
Analysis of spliced and unspliced Rous sarcoma virus RNAs early and late after infection of chicken embryo fibroblasts: effect of cell culture conditions. Virology (1991) 0.96
Evidence of methylation of B77 avian sarcoma virus genome RNA subunits. J Virol (1976) 0.96
Inhibition of RNA splicing at the Rous sarcoma virus src 3' splice site is mediated by an interaction between a negative cis element and a chicken embryo fibroblast nuclear factor. J Virol (1995) 0.95
Short consensus repeat domain 1 of decay-accelerating factor is required for enterovirus 70 binding. J Virol (1998) 0.95
MHV nucleocapsid synthesis in the presence of cycloheximide and accumulation of negative strand MHV RNA. Virus Res (1986) 0.94
Genetic characterization of Sabin types 1 and 3 poliovaccine virus following serial passage in the human intestinal tract. Biologicals (1992) 0.93
Binding of equine infectious anemia virus rev to an exon splicing enhancer mediates alternative splicing and nuclear export of viral mRNAs. Mol Cell Biol (2000) 0.93
Synthesis of virus-specific polypeptides and genomic RNA during the replicative cycle of Pichinde virus. J Virol (1982) 0.93
Molecular characterization and expression of a N-acetylneuraminate lyase gene from Trichomonas vaginalis. Mol Biochem Parasitol (1997) 0.92
Overlapping cis sites used for splicing of HIV-1 env/nef and rev mRNAs. J Biol Chem (1998) 0.92
The upstream, direct repeat sequence of Prague A Rous sarcoma virus is deficient in mediating efficient Gag assembly and particle release. Virology (1998) 0.91
Evolution of the fusion protein gene of human parainfluenza virus 3. Virus Res (1992) 0.89
Selection and characterization of replication-competent revertants of a Rous sarcoma virus src gene oversplicing mutant. J Virol (1996) 0.88
Rapid synthesis and cloning of complementary DNA from any RNA molecule into plasmid and phage M13 vectors. Gene (1988) 0.87
Origin of reovirus oligo(A). J Virol (1974) 0.87
Differences in coupling of energy to glycine and phenylalanine transport in aerobically grown Escherichia coli. J Bacteriol (1975) 0.87
Sensitivity and specificity of enzyme immunofiltration and DNA hybridization for the detection of HCMV-infected cells. J Virol Methods (1987) 0.86
Defective interfering particles of human parainfluenza virus 3. Virology (1987) 0.86
Selective inhibition of splicing at the avian sarcoma virus src 3' splice site by direct-repeat posttranscriptional cis elements. J Virol (2000) 0.84
Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors. Mol Cell Biol (1995) 0.84
Avian sarcoma virus RNA synthesis, RNA splicing and virus production in human foreskin fibroblasts: effect of co-infection with human cytomegalovirus. J Gen Virol (1993) 0.83
Pichinde virus L and S RNAs contain unique sequences. J Virol (1981) 0.83
Regression of v-src DNA-induced sarcomas is under host genetic control. Virology (1991) 0.82
Selective inhibition of avian sarcoma virus protein synthesis in 3-deazaadenosine-treated infected chicken embryo fibroblasts. J Virol (1981) 0.80
Nucleotide sequence analysis of Urabe mumps vaccine strain that caused meningitis in vaccine recipients. Vaccine (1991) 0.80
Repair of a Rev-minus human immunodeficiency virus type 1 mutant by activation of a cryptic splice site. J Virol (2001) 0.79
Sequence homology between Moloney murine sarcoma virus and Moloney leukemia virus RNA. J Virol (1976) 0.78
Biological characteristics of genetic variants of Urabe AM9 mumps vaccine virus. Virus Res (2000) 0.78
Nucleotide sequence of the human parainfluenza virus 3 matrix protein gene. Nucleic Acids Res (1987) 0.78
Molecular cloning of the ADE1 gene of Saccharomyces cerevisiae and stability of the transformants. Gene (1984) 0.77
Function and immunogenicity of human parainfluenza virus 3 glycoproteins expressed by recombinant adenoviruses. Virus Res (1992) 0.77
Coupling of glycine and alanine transport to respiration in cells of Escherichia coli. Can J Biochem (1975) 0.77
A Trichomonas vaginalis cDNA with partial protein sequence homology with a Plasmodium falciparum excreted protein ABRA. Appl Parasitol (1993) 0.76
Particles of reduced infectivity and deficient in envelope glycoproteins are produced in cycloleucine-treated B77 avian sarcoma virus-infected chicken embryo fibroblasts. J Virol (1983) 0.75
Viral RNA and protein synthesis in two LLC-MK2 cell lines persistently infected with human parainfluenza virus 3. Virus Res (1990) 0.75